{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/AKTX/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-15T11:30:24.035Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":1060,"canonical_name":"Akari Therapeutics Plc","cik":"0001541157","uei":null,"lei":null,"duns":null,"ticker":"AKTX"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":38},"count":38,"timeline":[{"ts":"2026-10-14","kind":"sec.filing","form_type":"3","title":"3 — Akari Therapeutics Plc — 2026-10-14","url_slug":"/sec/cik-0001541157/3/0001493152-26-047057","accession_number":"0001493152-26-047057","importance":30},{"ts":"2026-10-14","kind":"sec.filing","form_type":"4","title":"4 — Akari Therapeutics Plc — 2026-10-14","url_slug":"/sec/cik-0001541157/4/0001493152-26-047058","accession_number":"0001493152-26-047058","importance":30},{"ts":"2026-10-01","kind":"sec.filing","form_type":"DEF 14A","title":"DEF 14A — Akari Therapeutics Plc — 2026-10-01","url_slug":"/sec/cik-0001541157/def-14a/0001493152-26-045371","accession_number":"0001493152-26-045371","importance":40},{"ts":"2026-10-01","kind":"sec.filing","form_type":"8-K","title":"8-K — Akari Therapeutics Plc — 2026-10-01","url_slug":"/sec/cik-0001541157/8-k/0001493152-26-045364","accession_number":"0001493152-26-045364","importance":35},{"ts":"2026-10-01","kind":"sec.filing","form_type":"4","title":"4 — Akari Therapeutics Plc — 2026-10-01","url_slug":"/sec/cik-0001541157/4/0001493152-26-045366","accession_number":"0001493152-26-045366","importance":30},{"ts":"2026-08-19","kind":"sec.filing","form_type":"4","title":"4 — Akari Therapeutics Plc — 2026-08-19","url_slug":"/sec/cik-0001541157/4/0001493152-26-039246","accession_number":"0001493152-26-039246","importance":30},{"ts":"2026-08-13","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Akari Therapeutics Plc — 2026-08-13","url_slug":"/sec/cik-0001541157/10-q/0001493152-26-037730","accession_number":"0001493152-26-037730","importance":45},{"ts":"2026-08-13","kind":"sec.filing","form_type":"8-K","title":"8-K — Akari Therapeutics Plc — 2026-08-13","url_slug":"/sec/cik-0001541157/8-k/0001493152-26-037736","accession_number":"0001493152-26-037736","importance":35},{"ts":"2026-08-12","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Akari Therapeutics Plc — 2026-08-12","url_slug":"/sec/cik-0001541157/schedule-13g/0000927971-26-000091","accession_number":"0000927971-26-000091","importance":55},{"ts":"2026-08-07","kind":"sec.filing","form_type":"SCHEDULE 13G","title":"SCHEDULE 13G — Akari Therapeutics Plc — 2026-08-07","url_slug":"/sec/cik-0001541157/schedule-13g/0001952614-26-000004","accession_number":"0001952614-26-000004","importance":55},{"ts":"2026-08-05","kind":"sec.filing","form_type":"4","title":"4 — Akari Therapeutics Plc — 2026-08-05","url_slug":"/sec/cik-0001541157/4/0001493152-26-036231","accession_number":"0001493152-26-036231","importance":30},{"ts":"2026-07-17","kind":"sec.filing","form_type":"4","title":"4 — Akari Therapeutics Plc — 2026-07-17","url_slug":"/sec/cik-0001541157/4/0001493152-26-033634","accession_number":"0001493152-26-033634","importance":30},{"ts":"2026-07-16","kind":"sec.insider.a","reporter":"Farag Kameel D.","title":"Interim CFO","shares":1130,"price_per_share":11.5,"usd_value":12995,"security_title":"American Depositary Shares representing Ordinary Shares","importance":15.012995},{"ts":"2026-07-13","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Akari Therapeutics Plc — 2026-07-13","url_slug":"/sec/cik-0001541157/effect/9999999995-26-002279","accession_number":"9999999995-26-002279","importance":30},{"ts":"2026-07-10","kind":"sec.filing","form_type":"S-3/A","title":"S-3/A — Akari Therapeutics Plc — 2026-07-10","url_slug":"/sec/cik-0001541157/s-3-a/0001493152-26-032841","accession_number":"0001493152-26-032841","importance":30},{"ts":"2026-07-08","kind":"sec.filing","form_type":"S-3/A","title":"S-3/A — Akari Therapeutics Plc — 2026-07-08","url_slug":"/sec/cik-0001541157/s-3-a/0001493152-26-032503","accession_number":"0001493152-26-032503","importance":30},{"ts":"2026-07-07","kind":"sec.filing","form_type":"EFFECT","title":"EFFECT — Akari Therapeutics Plc — 2026-07-07","url_slug":"/sec/cik-0001541157/effect/9999999995-26-002205","accession_number":"9999999995-26-002205","importance":30},{"ts":"2026-07-07","kind":"sec.insider.m","reporter":"Patel Samir Rashmikant","title":"","shares":1209,"price_per_share":8,"usd_value":9672,"security_title":"American Depositary Shares representing Ordinary Shares","importance":15.009672},{"ts":"2026-07-07","kind":"sec.insider.m","reporter":"Patel Samir Rashmikant","title":"","shares":15466,"price_per_share":0.0004,"usd_value":6,"security_title":"American Depositary Shares representing Ordinary Shares","importance":15.0000061864},{"ts":"2026-07-07","kind":"sec.insider.m","reporter":"Patel Samir Rashmikant","title":"","shares":5799,"price_per_share":0.0004,"usd_value":2,"security_title":"American Depositary Shares representing Ordinary Shares","importance":15.0000023196},{"ts":"2026-07-02","kind":"sec.filing","form_type":"8-K","title":"8-K — Akari Therapeutics Plc — 2026-07-02","url_slug":"/sec/cik-0001541157/8-k/0001493152-26-031972","accession_number":"0001493152-26-031972","importance":35},{"ts":"2026-07-02","kind":"sec.filing","form_type":"S-3","title":"S-3 — Akari Therapeutics Plc — 2026-07-02","url_slug":"/sec/cik-0001541157/s-3/0001493152-26-031967","accession_number":"0001493152-26-031967","importance":30},{"ts":"2026-06-26","kind":"sec.filing","form_type":"8-K","title":"8-K — Akari Therapeutics Plc — 2026-06-26","url_slug":"/sec/cik-0001541157/8-k/0001493152-26-030341","accession_number":"0001493152-26-030341","importance":35},{"ts":"2026-06-26","kind":"sec.filing","form_type":"S-1/A","title":"S-1/A — Akari Therapeutics Plc — 2026-06-26","url_slug":"/sec/cik-0001541157/s-1-a/0001493152-26-030330","accession_number":"0001493152-26-030330","importance":30},{"ts":"2026-06-25","kind":"sec.filing","form_type":"4","title":"4 — Akari Therapeutics Plc — 2026-06-25","url_slug":"/sec/cik-0001541157/4/0001493152-26-030207","accession_number":"0001493152-26-030207","importance":30},{"ts":"2026-06-25","kind":"sec.filing","form_type":"4","title":"4 — Akari Therapeutics Plc — 2026-06-25","url_slug":"/sec/cik-0001541157/4/0001493152-26-030210","accession_number":"0001493152-26-030210","importance":30},{"ts":"2026-06-24","kind":"sec.insider.a","reporter":"Farag Kameel D.","title":"Interim CFO","shares":7353,"price_per_share":3.74,"usd_value":27500,"security_title":"American Depositary Shares representing Ordinary Shares","importance":15.02750022},{"ts":"2026-06-24","kind":"sec.insider.a","reporter":"Farag Kameel D.","title":"Interim CFO","shares":1395,"price_per_share":9.32,"usd_value":13001,"security_title":"American Depositary Shares representing Ordinary Shares","importance":15.0130014},{"ts":"2026-06-24","kind":"sec.insider.a","reporter":"Farag Kameel D.","title":"Interim CFO","shares":3725,"price_per_share":3.49,"usd_value":13000,"security_title":"American Depositary Shares representing Ordinary Shares","importance":15.01300025},{"ts":"2026-06-24","kind":"sec.insider.a","reporter":"Farag Kameel D.","title":"Interim CFO","shares":1000,"price_per_share":13,"usd_value":13000,"security_title":"American Depositary Shares representing Ordinary Shares","importance":15.013},{"ts":"2026-06-24","kind":"sec.insider.a","reporter":"Farag Kameel D.","title":"Interim CFO","shares":2539,"price_per_share":5.12,"usd_value":13000,"security_title":"American Depositary Shares representing Ordinary Shares","importance":15.01299968},{"ts":"2026-06-24","kind":"sec.insider.a","reporter":"Farag Kameel D.","title":"Interim CFO","shares":1570,"price_per_share":8.28,"usd_value":13000,"security_title":"American Depositary Shares representing Ordinary Shares","importance":15.0129996},{"ts":"2026-06-24","kind":"sec.insider.a","reporter":"Farag Kameel D.","title":"Interim CFO","shares":1248,"price_per_share":10.02,"usd_value":12505,"security_title":"American Depositary Shares representing Ordinary Shares","importance":15.01250496},{"ts":"2026-06-03","kind":"sec.filing","form_type":"D","title":"D — Akari Therapeutics Plc — 2026-06-03","url_slug":"/sec/cik-0001541157/d/0001493152-26-027117","accession_number":"0001493152-26-027117","importance":30},{"ts":"2026-05-21","kind":"sec.filing","form_type":"RW","title":"RW — Akari Therapeutics Plc — 2026-05-21","url_slug":"/sec/cik-0001541157/rw/0001493152-26-024741","accession_number":"0001493152-26-024741","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"10-Q","title":"10-Q — Akari Therapeutics Plc — 2026-05-19","url_slug":"/sec/cik-0001541157/10-q/0001493152-26-024446","accession_number":"0001493152-26-024446","importance":45},{"ts":"2026-05-18","kind":"sec.filing","form_type":"NT 10-Q","title":"NT 10-Q — Akari Therapeutics Plc — 2026-05-18","url_slug":"/sec/cik-0001541157/nt-10-q/0001493152-26-024230","accession_number":"0001493152-26-024230","importance":30},{"ts":"2026-05-08","kind":"sec.filing","form_type":"S-1","title":"S-1 — Akari Therapeutics Plc — 2026-05-08","url_slug":"/sec/cik-0001541157/s-1/0001493152-26-022019","accession_number":"0001493152-26-022019","importance":65}]}